108 related articles for article (PubMed ID: 35219213)
1. Retraction notice to "G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway" [J. Reprod. Immunol. 140C (2020) 103129].
Qiao HF; Liu YL; You J; Zheng YL; Chen LP; Lu XY; Du L; Shan F; Liu MH
J Reprod Immunol; 2022 Mar; 150():103495. PubMed ID: 35219213
[No Abstract] [Full Text] [Related]
2. G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.
Qiao HF; Liu YL; You J; Zheng YL; Chen LP; Lu XY; Du L; Shan F; Liu MH
J Reprod Immunol; 2020 Aug; 140():103129. PubMed ID: 32334286
[TBL] [Abstract][Full Text] [Related]
3. Retraction notice to "MiR-374b increases the CIK expression and mediates biological function changes in cervical cancer cells by targeting the PD-1/PD-L1 signaling pathway" [J. Reprod. Immunol. 143C (2021) 103265].
Wang C; Kuang L; Han L
J Reprod Immunol; 2022 Mar; 150():103498. PubMed ID: 35217239
[No Abstract] [Full Text] [Related]
4. Retraction notice to "Differential expression of miR-130a-3p modulate ovarian epithelial carcinoma (OEC) cell development and could be a biomarker for OEC" [J. Reprod. Immunol. 145C (2021) 103310].
Alrashed MM; Ahmad M; Yongmei W; Xiuyeng W
J Reprod Immunol; 2022 Mar; 150():103497. PubMed ID: 35217238
[No Abstract] [Full Text] [Related]
5. Resveratrol upregulates miR-455-5p to antagonize cisplatin ototoxicity via modulating the PTEN-PI3K-AKT axis.
Liu Y; Wu H; Zhang F; Yang J; He J
Biochem Cell Biol; 2021 Jun; 99(3):385-395. PubMed ID: 34077275
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
7. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H
Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447
[TBL] [Abstract][Full Text] [Related]
8. miR-205-5p Mediated Downregulation of PTEN Contributes to Cisplatin Resistance in C13K Human Ovarian Cancer Cells.
Shi X; Xiao L; Mao X; He J; Ding Y; Huang J; Peng C; Xu Z
Front Genet; 2018; 9():555. PubMed ID: 30510566
[TBL] [Abstract][Full Text] [Related]
9. MiR-221/222 promote chemoresistance to cisplatin in ovarian cancer cells by targeting PTEN/PI3K/AKT signaling pathway.
Amini-Farsani Z; Sangtarash MH; Shamsara M; Teimori H
Cytotechnology; 2018 Feb; 70(1):203-213. PubMed ID: 28887606
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L
Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
[TBL] [Abstract][Full Text] [Related]
11. MiR-129-5p inhibits autophagy and apoptosis of H9c2 cells induced by hydrogen peroxide via the PI3K/AKT/mTOR signaling pathway by targeting ATG14.
Zhang H; Zhang X; Zhang J
Biochem Biophys Res Commun; 2018 Nov; 506(1):272-277. PubMed ID: 30348524
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of miR-503 contributes to the development of drug resistance in ovarian cancer by targeting PI3K p85.
Wu D; Lu P; Mi X; Miao J
Arch Gynecol Obstet; 2018 Mar; 297(3):699-707. PubMed ID: 29327155
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K/AKT signaling pathway by targeting PAX6.
Liu Y; Liang G; Wang H; Liu Z
Pathol Res Pract; 2019 Dec; 215(12):152641. PubMed ID: 31727502
[TBL] [Abstract][Full Text] [Related]
14. miR-33-5p knockdown attenuates abdominal aortic aneurysm progression via promoting target adenosine triphosphate-binding cassette transporter A1 expression and activating the PI3K/Akt signaling pathway.
Zhao L; Huang J; Zhu Y; Han S; Qing K; Wang J; Feng Y
Perfusion; 2020 Jan; 35(1):57-65. PubMed ID: 31170866
[TBL] [Abstract][Full Text] [Related]
15. Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer.
Chen Y; Cao XY; Li YN; Qiu YY; Li YN; Li W; Wang H
Am J Physiol Cell Physiol; 2018 Aug; 315(2):C225-C235. PubMed ID: 29719173
[TBL] [Abstract][Full Text] [Related]
16. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
17. MiR-200b-5p inhibits proliferation of ovarian cancer cells by targeting ATAD2 and regulating PI3K/AKT signaling pathway.
Wang AQ; Lv M; Xu YH; Xie PM; Dong YY
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9860-9868. PubMed ID: 33090389
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-493-5p suppresses colorectal cancer progression via the PI3K-Akt-FoxO3a signaling pathway.
Cui FC; Chen Y; Wu XY; Hu M; Qin WS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4212-4223. PubMed ID: 32373957
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
Jin H; Qiao F; Wang Y; Xu Y; Shang Y
Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
[TBL] [Abstract][Full Text] [Related]
20. Retraction notice to "Interplay of microRNAs to genetic, epigenetic, copy number variations of cervical cancer related genes" [J. Reprod. Immunol. 142C (2020) 103184].
Dai J; Wang L; Li L; Tian X; Shang Z; Li H
J Reprod Immunol; 2022 Mar; 150():103496. PubMed ID: 35217237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
